U.S. Lawmakers Approve Bill Bolstering FDA Authority on Pharma Ingredients

The U.S. Senate and House of Representatives have approved separate bills that would revise FDA’s ability to oversee certain provisions related to pharmaceutical ingredients and includes a generic drug user fee program. The bills will now move to a House and Senate conference to reconcile differences in the two versions. The legislation, if finalized by Congress, would represent a significant victory for Socma, which for years has been urging lawmakers to take steps to make sure U.S. makers of active pharmaceutical ingredients (APIs) do not face unfair...

If you have already signed up for access to Chemical Week Regulatory Watch, please log in here.

Forgot your user ID or password?
Click here to have it sent to you.